NEUROCRINE BIOSCIENC

NBIX
Delayed Quote. Delayed  - 05/14 04:00:00 pm
94.6USD +2.90%
Upcoming events on NEUROCRINE BIOSCIENCES, INC.
05/19/21 | 01:30pm Annual General Meeting
08/04/21 Interim 2021 Earnings Release (Projected)
11/03/21 Q3 2021 Earnings Release (Projected)
02/08/22 FY 2021 Earnings Release (Projected)

Past events on NEUROCRINE BIOSCIENCES, INC.
05/11/21 | 11:00amBank of America Healthcare Conference
05/05/21 | 04:30pmQ1 2021 Earnings Call
05/05/21 | 04:01pmQ1 2021 Earnings Release
04/17/21American Academy of Neurology Meeting - Poster # P14.145

Upcoming sector events for NEUROCRINE BIOSCIENCES, INC.
05/14/21 ACCELERON PHARMA INC. : American Thoracic Society International Conference - Sotatercept Analog RAP-011 Reduces Right Ventri
05/14/21 ACCELERON PHARMA INC. : American Thoracic Society International Conference - Sotatercept Analog RAP-011 Alleviates Cardiopul
05/14/21 | 08:30am ARGENX SE : Q1 2021 Earnings Call
05/14/21 SEAGEN INC. : Annual General Meeting

Past sector events for NEUROCRINE BIOSCIENCES, INC.
05/13/21 | 02:00pmGILEAD SCIENCES, INC. : Bank of America Health Care Conference
05/13/21 | 11:00amMODERNA, INC. : Bank of America Healthcare Conference
05/13/21PEPTIDREAM INC. : Q1 2021 Earnings Release
05/13/21CELLTRION, INC. : Q1 2021 Earnings Release (Projected)

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
1 046
1 058
-1,2%

1 136
Operating income
(EBITDA)
M $
Released
Forecast
Spread
192
178
7,6%

327
Operating profit
(EBIT)
M $
Released
Forecast
Spread
163
162
0,44%

259
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
107
129
-17%

244
Net income
M $
Released
Forecast
Spread
407
121
237%

232
EPS
$
Released
Forecast
Spread
4,16
1,23
239%

2,36
Announcement Date02/04/2021


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread
237
251
-5,8%

275
Operating income
(EBITDA)
M $
Released
Forecast
Spread
44,3
47,1
-5,9%

80,5
Operating profit
(EBIT)
M $
Released
Forecast
Spread
31,5
62,8
-50%

64,4
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
27,2
59,0
-54%

62,0
Net income
M $
Released
Forecast
Spread
32,1
46,6
-31%

55,0
EPS
$
Released
Forecast
Spread
0,33
0,50
-34%

0,55
Announcement Date05/05/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise